Neurona Therapeutics: $120 Million Raised To Advance Pipeline Of Regenerative Cell Therapy Candidates For Chronic Neurological Disorders
By Amit Chowdhry ● Feb 9, 2024
Neurona Therapeutics (a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders) announced the successful completion of a $120 million financing co-led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors, including The Column Group, LYFE Capital, Schroders Capital, Willett Advisors, Ysios Capital Partners, Euclidean Capital, SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund, Sphera Biotech Master Fund LP, Spur Capital Partners, UCB Ventures, and UC Investments.